Research
Hormonal
Semaglutide 2.4 mg facilitates substantial, sustainable weight loss and improves cardiometabolic health by reducing 'food noise' and maladaptive eating behaviors.
Semaglutide 2.4 mg is an effective tool for reducing 'food noise' and enabling sustainable weight loss when lifestyle changes alone are insufficient. It works by altering hormonal signals related to appetite and satiety.
ModerateSupportsMEDIUM confidence
Users consistently reported slow but sustainable weight loss with semaglutide 2.4 mg... Users reported a significant reduction in 'food noise,' characterized by decreased food-related intrusive thoughts and maladaptive eating behaviors.
Why this rating
Qualitative analysis of Reddit posts provides real-world anecdotal evidence but lacks controlled clinical rigor.
Source
A Qualitative Analysis of Patient Experiences Using Semaglutide 2.4 mg for Weight Loss
Eion Plenn et al. · Obesity Science & Practice · 2025
DOI 10.1002/osp4.70085
cross_sectional · n=660Cited 3×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →